Avicanna (TSX:AVCN)
Edit

Avicanna (TSX:AVCN)

http://www.avicanna.com/
Last activity: 23.09.2024
Active
Categories: BioTechDeliveryMedTechNewsProductSpace
A Leader in Biopharmaceutical Advancements in Cannabis
Likes
682
Followers
1.01K
Mentions
8
Location: Canada, Ontario, Toronto
Employees: 51-200
Phone: +1 647-243-5283
Total raised: $1.6M
Founded date: 2015

Investors 1

Funding Rounds 1

DateSeriesAmountInvestors
29.05.2017Seed$1.6M-

Mentions in press and media 8

DateTitleDescription
23.09.2024Avicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.ca1000 patient study on impact of medical cannabis on pain, sleep, anxiety, depression, and epilepsy Study to be led by Dr. Hance Clarke President of The Canadian Pain Society and the CCIC TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Avicanna ...
14.08.2024Avicanna Reports Q2 2024Q2 2024 revenue of $6.1 million an increase of 85% over Q2 2023 Completion of two real world evidence trials on Epidermolysis Bullosa and Musculoskeletal Pain TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company)...
18.04.2024Avicanna Announces Closing of Non-brokered Private PlacementTORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cann...
14.11.2023Avicanna Reports Q3 2023 ResultsAcquisition of Medical Cannabis by Shoppers assets leading to the launch of MyMedi.ca. Record revenue of $6.27M, representing an increase of 90% over Q2, and 713% year-over-year. Improvements in performance including 46% consolidated gross ...
26.06.2023Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement for Avicanna’s Proprietary SEDDS Technology Capsules for Canadian and International markets/EIN News/ -- Avicanna’s proprietary SEDDS technology capsules are designed for enhanced and rapid absorption of cannabinoids. Avicanna and Medipharm intend to commercialize various formulations of Avicanna’s proprietary SEDDS technology ca...
29.05.2023Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business/EIN News/ -- TORONTO, May 29, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-de...
24.02.2019Why CBD Water Is Not Really A Thing And May Even Be DangerousTwo identical drams of CBD from Avicanna's laboratories demonstrate the lighter, pinkish one on the... [+] right was exposed to oxygen. © Sara Brittany Somerset
26.05.2017Avicanna Closes C$1.6m in Seed FundingAvicanna Inc., a Toronto, Canada-based biotechnology company focused on innovative approaches and technologies in the medical cannabis sector, completed its C$1.6m seed financing. The company intends to use the funds for the clinical develo...

Reviews 0

Sign up to leave a review

Sign up Log In